myocardial infarction secondary to inflammatory myofibroblastic tumor obstruction of the left main: treated with primary pci
Authors
abstract
conclusions the patient underwent surgery several days later with complete resection of the tumor and coronary stent retrieval but his left ventricular ejection fraction remained poor after several months and he was referred for cardiac transplantation. introduction cardiac inflammatory myofibroblastic tumor is a rare tumor that can cause potentially fatal outcomes. case presentation we describe a case where the tumor originated on the mitral valve and extended through the left ventricular outflow tract and aortic valve and into the left main artery obstructing it. due to the hemodynamic instability of the patient, we proceeded for cardiac catheterization with the intention to aspirate the mass but were forced to do percutaneous intervention to stabilize the patient and bridge him to surgery.
similar resources
Myocardial Infarction Secondary to Inflammatory Myofibroblastic Tumor Obstruction of the Left Main: Treated With Primary PCI
INTRODUCTION Cardiac inflammatory myofibroblastic tumor is a rare tumor that can cause potentially fatal outcomes. CASE PRESENTATION We describe a case where the tumor originated on the mitral valve and extended through the left ventricular outflow tract and aortic valve and into the left main artery obstructing it. Due to the hemodynamic instability of the patient, we proceeded for cardiac c...
full textInfantile Inflammatory Myofibroblastic Tumor with Terminal Ileum Obstruction
Inflammatory myofibroblastic tumor is an uncommon benign neoplasm and its presentation in small bowel is rare. Due to clinical manifestation, laboratory data and radiologic results, there is an increased risk of over diagnosis as malignant tumors particularly malignant lymphoma in childhood therefore may be resulting in wrong therapeutic approach. However pathologic findings could be demonstrat...
full textinfantile inflammatory myofibroblastic tumor with terminal ileum obstruction
inflammatory myofibroblastic tumor is an uncommon benign neoplasm and its presentation in small bowel is rare. due to clinical manifestation, laboratory data and radiologic results, there is an increased risk of over diagnosis as malignant tumors particularly malignant lymphoma in childhood therefore may be resulting in wrong therapeutic approach. however pathologic findings could be demonstrat...
full textRecurrence of inflammatory myofibroblastic tumor in bladder secondary to prostate treated with laparoscopic radical cystectomy
BACKGROUND Inflammatory myofibroblastic tumor (IMT) is a rare borderline tumor. The nomenclature of this disease is confused in the literature. CASE REPORT In this report, the case of a 62-year-old man with IMT recurrence of bladder secondary to prostate is presented. The possible etiology of IMT is discussed, along with its clinical manifestation and pathological features. The patient receiv...
full textPrimary inflammatory myofibroblastic tumor of the trachea
Inflammatory myofibroblastic tumors (IMTs) are rare neoplasms that can involve the airway. Recent studies have shown their malignant behavior with local recurrence and potential metastatic spread; half of the cases are associated with anaplastic lymphoma kinase gene rearrangement. Complete surgical resection is recommended, when feasible. We present a case of a 26-year-old woman admitted to our...
full textInflammatory Myofibroblastic Tumor of the Larynx: A Case Report
Introduction: Inflammatory myofibroblastic pseudotumors are initially described in the lung and various extrapulmonary sites such as the orbits, palatine tonsils, ears, gingiva, pterygomaxillary space, and periodontal tissues. These tumors rarely involve the larynx and predilection to the glottis occurs in an indolent manner. Case Report This case describes a laryngeal myofibroblastic tumor i...
full textMy Resources
Save resource for easier access later
Journal title:
research in cardiovascular medicineجلد ۵، شماره ۳، صفحات ۰-۰
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023